Capha Pharmaceuticals Inc. Stock

Stocks

25-07-31	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-05-28	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-24	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-04-23	Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
24-10-17	Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-07-29	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
24-05-30	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-04-26	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
24-04-25	Capha Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt	CI
23-11-28	Capha Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
23-08-28	Capha Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
23-05-30	Capha Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
23-04-26	Capha Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Manager	Title	Age	Since
James Brown CEO	Chief Executive Officer	-	2004-01-12

Director	Title	Age	Since
Janice Brown BRD	Director/Board Member	-	2004-01-12
Herbert Leary BRD	Director/Board Member	-	2010-10-24
James Brown CHM	Chairman	-	2002-10-30

Date	Insider	Type	Main position	Quantity	% Market Cap.
21-11-10	Janice Brown	Free	Director	888,036	1.3783%
21-11-10	James Brown	Free	Chief Executive Officer	888,036	1.3783%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CAPHA PHARMACEUTICALS INC.	-.--%	-99.00%	-	-	64
ELI LILLY AND COMPANY	-1.14%	-2.43%	+53.72%	+159.07%	1,082B
JOHNSON & JOHNSON	-1.41%	+0.32%	+66.23%	+60.48%	633B
ABBVIE INC.	-2.42%	+0.18%	+34.59%	+85.62%	461B
ROCHE HOLDING AG	-0.26%	+0.53%	+31.00%	+25.82%	338B
ASTRAZENECA PLC	-2.46%	-1.38%	+36.42%	+36.52%	299B
NOVARTIS AG	-2.20%	-0.87%	+27.50%	+42.69%	291B
NOVO NORDISK A/S	-1.77%	+1.97%	-28.85%	-40.66%	222B
AMGEN INC.	-2.06%	+1.63%	+22.87%	+64.34%	202B
GILEAD SCIENCES, INC.	-1.26%	+2.60%	+15.98%	+70.00%	163B
Average	-1.50%	+0.62%	+28.83%	+55.99%	410.27B
Weighted average by Cap.	-1.55%	-0.22%	+39.61%	+80.57%